Aminex (LON:AEX) Stock Passes Above 200 Day Moving Average - Here's What Happened

Key Points

• Aminex shares rose above their 200‑day moving average, with the 200‑day MA at GBX 1.93 and the stock trading up about 9% to GBX 2.34 (high GBX 2.40) on volume of 7,562,010 shares.
• Insider sale: Director Tom Mackay sold 1,528,947 shares on April 28 at an average of GBX 2, totaling £30,578.94; insiders now own 5.89% of the company.
• Aminex is an oil and gas exploration and production company focused mainly in Tanzania, with a market capitalization of £102.31 million and a negative P/E of -19.07.

Aminex PLC (LON:AEX - )'s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1.93 and traded as high as GBX 2.40. Aminex shares last traded at GBX 2.34, with a volume of 7,562,010 shares changing hands.

Aminex Stock Up 9.0%

The company's fifty day moving average price is GBX 2.25 and its 200-day moving average price is GBX 1.93. The stock has a market capitalization of £102.31 million, a PE ratio of -19.07 and a beta of -0.03.

Insider Activity

In other news, insider Tom Mackay sold 1,528,947 shares of Aminex stock in a transaction that occurred on Tuesday, April 28th. The shares were sold at an average price of GBX 2, for a total transaction of £30,578.94. Insiders own 5.89% of the company's stock.

About Aminex

Aminex PLC, together with its subsidiaries, engages in the exploration, appraisal, development, and production of oil and gas assets, reserves, and resources. The company operates through Producing Oil and Gas Properties, Exploration Activities, and Oilfield Services segments. Its properties include the Kiliwani South, Ruvuma PSA, and Nyuni Area PSA exploration licenses located primarily in Tanzania. Aminex PLC was incorporated in 1979 and is based in Dublin, Ireland.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.